Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: Fort Worth TX, San Antonio TX, Sioux Falls SD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase 1, Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Fort Worth TX, Round Rock TX, Shreveport LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Fort Worth TX, Dallas TX, Houston TX, Kansas City MO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase 3, Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
for
Renal Insufficiency, Chronic
Location: Fort Worth TX, Stephenville TX, Sugar Land TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07624305
Phase 3, Recruiting
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
for
ER-Positive HER2-Negative Breast Cancer
Location: Fort Worth TX, Kingwood TX, Marietta GA, Edgewood KY
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07647328
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
for
CKD, Metabolic Acidosis
Location: Fort Worth TX, Houston TX, San Antonio TX, Van Vleck TX,
Sponsor: Renibus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07355062
Phase 3, Recruiting
WRAP North America
for
Venous Stenosis, Venous Occlusion
Location: Fort Worth TX, Humble TX, Dothan AL, Lexington KY,
Sponsor: Merit Medical Systems, Inc.
Sex: All
Age: 18+
Code: NCT06807099
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Fort Worth TX, Mansfield TX, Dallas TX,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Kingwood TX, Houston TX, Odessa TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Fort Worth TX, Irving TX, Palestine TX, Round Rock TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, Shreveport LA, San Antonio TX,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Fort Worth TX, San Antonio TX, Westwood KS,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07259317
Phase 2, Recruiting
Obalon Navigation/Touch System Post-Approval Study
for
Obesity
Location: Fort Worth TX, Flower Mound TX
Sponsor: Obalon Therapeutics, Inc.
Sex: All
Age: 22+
Code: NCT04095481
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
for
Amblyopia
Location: Fort Worth TX, Crestview FL, Indianapolis IN,
Sponsor: Luminopia
Sex: All
Age: 0+
Code: NCT06429280
Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Fort Worth TX, Oklahoma City OK, San Antonio TX,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase 3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Fort Worth TX, Dallas TX, Tyler TX, Abilene TX,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Austin TX, San Antonio TX, Tulsa OK,